Oncogene - Table of Contents alert Volume 35 Issue 33

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 35, Issue 33 (August 2016) In this issue Original Articles Short Communications Erratum Corrigendum Also new AOP Advertisement   Open for Submissions npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.  Explore the benefits of submitting your manuscript >> Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage Original Articles Top CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2 C García-Limones, M Lara-Chica, C Jiménez-Jiménez, M Pérez, P Moreno, E Muñoz and M A Calzado Oncogene 2016 35: 4289-4301; advance online publication, January 11, 2016; 10.1038/onc.2015.495 Abstract | Full Text Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways OPEN J A Somarelli, D Schaeffer, M S Marengo, T Bepler, D Rouse, K E Ware, A J Hish, Y Zhao, A F Buckley, J I Epstein, A J Armstrong, D M Virshup and M A Garcia-Blanco Oncogene 2016 35: 4302-4311; advance online publication, January 11, 2016; 10.1038/onc.2015.497 Abstract | Full Text Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression R Rupaimoole, C Ivan, D Yang, K M Gharpure, S Y Wu, C V Pecot, R A Previs, A S Nagaraja, G N Armaiz-Pena, M McGuire, S Pradeep, L S Mangala, C Rodriguez-Aguayo, L Huang, M Bar-Eli, W Zhang, G Lopez-Berestein, G A Calin and A K Sood Oncogene 2016 35: 4312-4320; advance online publication, January 4, 2016; 10.1038/onc.2015.492 Abstract | Full Text SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment OPEN Y Sun, D Zhu, F Chen, M Qian, H Wei, W Chen and J Xu Oncogene 2016 35: 4321-4334; advance online publication, January 11, 2016; 10.1038/onc.2015.494 Abstract | Full Text FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression J C Zhao, K-W Fong, H-J Jin, Y A Yang, J Kim and J Yu Oncogene 2016 35: 4335-4344; advance online publication, January 11, 2016; 10.1038/onc.2015.496 Abstract | Full Text Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC OPEN M A Taylor, M Wappett, O Delpuech, H Brown and C M Chresta Oncogene 2016 35: 4345-4357; advance online publication, January 18, 2016; 10.1038/onc.2015.499 Abstract | Full Text The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα M Ying, L Zhang, Q Zhou, X Shao, J Cao, N Zhang, W Li, H Zhu, B Yang and Q He Oncogene 2016 35: 4358-4367; advance online publication, January 18, 2016; 10.1038/onc.2015.503 Abstract | Full Text A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation OPEN E Grassilli, F Pisano, A Cialdella, S Bonomo, C Missaglia, M G Cerrito, L Masiero, L Ianzano, F Giordano, V Cicirelli, R Narloch, F D’Amato, B Noli, G L Ferri, B E Leone, G Stanta, S Bonin, K Helin, R Giovannoni and M Lavitrano Oncogene 2016 35: 4368-4378; advance online publication, January 25, 2016; 10.1038/onc.2015.504 Abstract | Full Text VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors D Grun, G Adhikary and R L Eckert Oncogene 2016 35: 4379-4387; advance online publication, January 25, 2016; 10.1038/onc.2015.507 Abstract | Full Text STAT3 selectively interacts with Smad3 to antagonize TGF-β G Wang, Y Yu, C Sun, T Liu, T Liang, L Zhan, X Lin and X-H Feng Oncogene 2016 35: 4388-4398; advance online publication, November 30, 2015; 10.1038/onc.2015.446 Abstract | Full Text Short Communications Top A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response C A Melo, N Léveillé, K Rooijers, P J Wijchers, G Geeven, A Tal, S A Melo, W de Laat and R Agami Oncogene 2016 35: 4399-4406; advance online publication, January 18, 2016; 10.1038/onc.2015.502 Abstract | Full Text Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis OPEN C Anadón, S Guil, L Simó-Riudalbas, C Moutinho, F Setien, A Martínez-Cardús, S Moran, A Villanueva, M Calaf, A Vidal, P A Lazo, I Zondervan, S Savola, T Kohno, J Yokota, L R de Pouplana and M Esteller Oncogene 2016 35: 4407-4413; advance online publication, December 7, 2015; 10.1038/onc.2015.469 Abstract | Full Text p19Arf is required for the cellular response to chronic DNA damage K T Bieging-Rolett, T M Johnson, C A Brady, V G Beaudry, N Pathak, S Han and L D Attardi Oncogene 2016 35: 4414-4421; advance online publication, January 4, 2016; 10.1038/onc.2015.490 Abstract | Full Text Erratum Top STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling G Wang, Y Yu, C Sun, T Liu, T Liang, L Zhan, X Lin and X-H Feng Oncogene 2016 35: 4422; advance online publication, June 27, 2016; 10.1038/onc.2016.145 Full Text Corrigendum Top Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis OPEN C Anadón, S Guil, L Simó-Riudalbas, C Moutinho, F Setien, A Martínez-Cardús, S Moran, A Villanueva, M Calaf, A Vidal, P A Lazo, I Zondervan, S Savola, T Kohno, J Yokota, L Ribas de Pouplana and M Esteller Oncogene 2016 35: 4422; advance online publication, June 27, 2016; 10.1038/onc.2016.27 Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.